Amid global relief rally following assurances from Bank of Japan, Fed officials

Complete ban on use of derivatives, will be made to furnish granular disclosures

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Soriatane Capsules, 10 mg, 17.5 mg, and 25 mg, of Stiefel Laboratories, Inc. (Stiefel).

The Indian rupee came off recent lows but consolidated in a narrow range to settle the day lower by 4 paise at 83.96 (provisional) against US dollar on Wednesday, weighed down by a recovery in the US dollar and geopolitical tensions in the Middle East. Higher international crude prices weighed on the currency although strength in domestic markets limited the downside. The benchmark S&P/BSE Sensex jumped 874.94 points, or 1.11 percent, to 79,468.01 – snapping a three-day losing streak amid gains in other Asian and European markets. The broader NSE Nifty index settled 304.95 points, or 1.27 percent, higher at 24,297.50 ahead of the Reserve Bank of India’s monetary policy decision due Thursday. At the interbank foreign exchange market, the local unit opened at 83.86 and touched an intraday low of 83.97 against the dollar during the session.

Domestic shares roared back to life today, snapping a three-day losing streak. The Nifty50 closed near 24,300, with all sectors in the green. Oil & gas and metals led the charge. Global markets cheered the Bank of Japan’s pledge to maintain stable rates. Domestically, DIIs continue to support the market, offsetting FII selling.